GREG CUNY to Bone Morphogenetic Protein Receptors, Type I
This is a "connection" page, showing publications GREG CUNY has written about Bone Morphogenetic Protein Receptors, Type I.
Connection Strength
0.204
-
Development of an ALK2-biased BMP type I receptor kinase inhibitor. ACS Chem Biol. 2013; 8(6):1291-302.
Score: 0.104
-
BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med. 2008 Dec; 14(12):1363-9.
Score: 0.077
-
Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood. 2011 May 05; 117(18):4915-23.
Score: 0.022